Literature DB >> 23948919

Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R.

Marie-Pierre Chaunu1, Vincent Deramecourt, Valérie Buée-Scherrer, Isabelle Le Ber, Alexis Brice, Nathalie Ehrle, Khalid El Hachimi, Michel Pluot, Claude-Alain Maurage, Serge Bakchine, Luc Buée.   

Abstract

Frontotemporal lobe degeneration includes a large spectrum of neurodegenerative disorders. Patients with frontotemporal dementia with parkinsonism linked to chromosome 17 exhibit heterogeneity in both clinical and neuropathological features. Here, we report the case of a young patient with a G389R mutation. This teenager girl was 17 years old when she progressively developed severe behavioral disturbances. First, she was considered to be suffering from atypical depression. After 2 years, she was referred to the department of neurology. By this time, the patient exhibited typical frontotemporal dementia with mild extrapyramidal disorders. The main behavioral features included apathy and reduced speech output. MRI and SPECT showed a frontotemporal atrophy and hypofixation, respectively. She died 7 years after onset. Three relatives on her father side had also died after early onset dementia. Genetic testing revealed a heterozygous guanine to cytosine mutation at the first base of codon 389 (Exon 13) of MAPT, the tau gene, resulting in a glycine to arginine substitution, in the patient and her non-affected father. Postmortem neuropathological and biochemical data indicate a Pick-like tau pathology but with phosphoserine 262-positive immunoreactivity. This case is remarkable because of the extremely early onset of the disease.

Entities:  

Keywords:  Early onset dementia; G389R mutation; MAPT; Pick bodies; frontotemporal lobar degeneration; tau protein

Mesh:

Substances:

Year:  2013        PMID: 23948919     DOI: 10.3233/JAD-130413

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.

Authors:  Pawel Tacik; Michael DeTure; Kelly M Hinkle; Wen-Lang Lin; Monica Sanchez-Contreras; Yari Carlomagno; Otto Pedraza; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

Review 2.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

3.  LRRK2 Promotes Tau Accumulation, Aggregation and Release.

Authors:  Patrícia Silva Guerreiro; Ellen Gerhardt; Tomás Lopes da Fonseca; Mathias Bähr; Tiago Fleming Outeiro; Katrin Eckermann
Journal:  Mol Neurobiol       Date:  2015-05-27       Impact factor: 5.590

4.  FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Authors:  Pawel Tacik; Michael A DeTure; Yari Carlomagno; Wen-Lang Lin; Melissa E Murray; Matthew C Baker; Keith A Josephs; Bradley F Boeve; Zbigniew K Wszolek; Neill R Graff-Radford; Joseph E Parisi; Leonard Petrucelli; Rosa Rademakers; Richard S Isaacson; Kenneth M Heilman; Ronald C Petersen; Dennis W Dickson; Naomi Kouri
Journal:  Brain Pathol       Date:  2016-10-05       Impact factor: 6.508

Review 5.  The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Authors:  Cheng-Cheng Zhang; Ang Xing; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

6.  Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.

Authors:  Elodie Leroux; Romain Perbet; Raphaëlle Caillierez; Kevin Richetin; Sarah Lieger; Jeanne Espourteille; Thomas Bouillet; Séverine Bégard; Clément Danis; Anne Loyens; Nicolas Toni; Nicole Déglon; Vincent Deramecourt; Susanna Schraen-Maschke; Luc Buée; Morvane Colin
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

Review 7.  Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Authors:  Carmen Gasca-Salas; Mario Masellis; Edwin Khoo; Binit B Shah; David Fisman; Anthony E Lang; Galit Kleiner-Fisman
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

8.  Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau's interaction with microtubules in axon-like processes.

Authors:  Benedikt Niewidok; Maxim Igaev; Frederik Sündermann; Dennis Janning; Lidia Bakota; Roland Brandt
Journal:  Mol Biol Cell       Date:  2016-08-31       Impact factor: 4.138

9.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

10.  Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies.

Authors:  Simon Dujardin; Katia Lécolle; Raphaëlle Caillierez; Séverine Bégard; Nadège Zommer; Cédrick Lachaud; Sébastien Carrier; Noëlle Dufour; Gwennaëlle Aurégan; Joris Winderickx; Philippe Hantraye; Nicole Déglon; Morvane Colin; Luc Buée
Journal:  Acta Neuropathol Commun       Date:  2014-01-30       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.